ArticleJournal of oral biology and craniofacial research
E-Cadherin is a diagnostic biomarker in the progression of oral epithelial dysplasia to squamous cell carcinoma.
Article in Journal of oral biology and craniofacial research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Association of Epithelial to Mesenchymal transition Markers on Prognosis and Clinicopathological Characteristics in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.Head and neck pathology · 2025Pooled it
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Oral squamous cell carcinoma is a common cancer of head and neck region with poor prognosis and may sometimes show a premalignant stage. Cell-cell adhesion molecules play an important role in the process of malignant transformation. E-cadherin, a cell-to-cell adhesion molecule, plays a crucial role in maintaining cell polarity and adhesion of epithelial cells. Aims: To assess the expression of E-cadherin in various grades of oral epithelial dysplasia and oral squamous cells carcinoma and compare it to unremarkable oral mucosa. Materials and methods: The study comprised a total sample size of 80 with 10 cases of unremarkable oral mucosa which is the control group, 40 cases of oral epithelial dysplasia and 30 cases of oral squamous cell carcinoma. One section was stained with haematoxylin and eosin to confirm the histopathological diagnosis and other section was stained immunohistochemically with E-cadherin. Results: The study found that E-cadherin expression was strongly positive in unremarkable mucosal epithelium, reduced in oral epithelial dysplasia, and gradually decreased as it progressed to oral squamous cell carcinoma. These findings were found to be statistically significant. Conclusion: The study found a correlation between E-cadherin expression loss and oral squamous cell carcinoma progression, suggesting that E-cadherin can serve as a diagnostic biomarker for malignant transformation of oral epithelial dysplasia and predict disease prognosis in oral squamous cell carcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.